Pilot Study of Daily Exemestane in Women With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer
Phase of Trial: Phase II
Latest Information Update: 31 Dec 2018
At a glance
- Drugs Exemestane (Primary)
- Indications Atypical endometrial hyperplasia; Endometrial cancer
- Focus Therapeutic Use
- 19 Dec 2018 Planned End Date changed from 1 Dec 2018 to 1 Jan 2020.
- 19 Dec 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Jan 2020.
- 31 Aug 2018 Biomarkers information updated